🔗 Visit the ClinicalTrials.gov page for NCT00459940
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. | Diabetes | 1998 | 6.53 |
| 2 | Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. | Metabolism | 2003 | 1.21 |
| 3 | Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. | Diabetes | 2001 | 1.05 |
| 4 | Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. | Am J Physiol Endocrinol Metab | 2003 | 0.92 |
| 5 | Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus. | Metabolism | 2002 | 0.79 |
| 6 | The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults. | J Clin Endocrinol Metab | 2002 | 0.77 |
| 7 | Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy. | J Endocrinol Invest | 1999 | 0.76 |